Navegar

Colección

Datos Estadísticas

Lista de

advanced cancer
12
"High RAC3 expression levels are required for induction and maintaining of cancer cell stemness" (2018) Panelo, L.C.;Machado, M.S.;Rubio, M.F. (...)Costas, M.A. Oncotarget. 9(5):5848-5860
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis" (2013) Fernández Vallone, V.B.;Hofer, E.L.;Choi, H. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 30(3):317-332
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients" (2002) De Cavanagh, E.M.V.;Honegger, A.E.;Hofer, E. (...)Fraga, C. Cancer. 94(12):3247-3251
"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296
"Bone marrow fibroblasts in patients with advanced lung cancer" (2001) Chasseing, N.A.;Hofer, E.;Bordenave, R.H. (...)Rumi, L.S. Brazilian Journal of Medical and Biological Research. 34(11):1457-1463
"Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: An EORTC Gynaecological Cancer Cooperative Group Study" (2000) Lhommé, C.;Vermerken, J.B.;Mickiewicz, E. (...)Pecorelli, S. European Journal of Cancer. 36(2):194-199
"Bone marrow fibroblastic progenitors in patients with advanced breast cancer" (1997) Chasseing, N.A.;Trejo, Y.G.;Bordenave, R.H. (...)Rumi, L.S. Breast Cancer Research and Treatment. 45(3):211-218